Teva Pharmaceutical Industries reported 3.33B in Operating Expenses for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
Abbvie ABBV:US $ 9518M 611M
Aerie Pharmaceuticals AERI:US $ 58.69M 1.5M
ALKERMES ALKS:US 299.3M 29.33M
Amarin AMRN:US 145.72M 2.21M
Amgen AMGN:US $ 5.7B 1.93B
AstraZeneca AZN:LN 7.09B 1.67B
Biogen BIIB:US $ 2289.3M 569.2M
Bristol Myers Squibb BMY:US $ 9.99B 666M
Coherus Biosciences CHRS:US $ 111.81M 138.59M
Eli Lilly And LLY:US $ 5336.7M 313.6M
Emergent Biosolutions EBS:US $ 383M 135.4M
Endo International Ordinary Shares ENDP:US $ 570.72M 35.49M
Flexion Therapeutics FLXN:US $ 45.06M 2.67M
Gilead Sciences GILD:US $ 3971M 438M
GlaxoSmithKline GSK:LN 6.42B 692M
Henry Schein HSIC:US $ 2756.88M 61.84M
Horizon Pharma HZNP:US $ 694.03M 191.61M
JAZZ PHA JAZZ:US $ 821.4M 375.94M
Lannett LCI:US $ 139.83M 30.31M
Merk MRK:US $ 9905M 839M
Novartis NOVN:VX 9.82B 464M
Pacira Pharmaceuticals PCRX:US $ 100.75M 1.16M
Patterson Companies PDCO:US $ 1654.4M 129.96M
Perrigo Ordinary Shares PRGO:US $ 1107M 148.4M
Pfizer PFE:US $ 13063M 3998M
Phibro Animal Health PAHC:US $ 201.12M 9.52M
Revance Therapeutics RVNC:US $ 89.14M 5.83M
Sun Pharmaceuticals SUNP:IN IR 81118.3M 4217.7M
Supernus Pharmaceuticals SUPN:US $ 107.22M 10.5M
Teva Pharmaceutical Industries TEVA:US 3.33B 220M
Xeris Pharmaceuticals Inc XERS:US $ 34.69M 9.76M
Zoetis ZTS:US $ 1.31B 128M